Literature DB >> 10892234

The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part I. Attention-Deficit/Hyperactivity Disorder.

S R Pliszka1, L L Greenhill, M L Crismon, A Sedillo, C Carlson, C K Conners, J T McCracken, J M Swanson, C W Hughes, M E Llana, M Lopez, M G Toprac.   

Abstract

OBJECTIVES: Expert consensus methodology was used to develop evidence-based, consensually agreed-upon medication treatment algorithms for attention-deficit/hyperactivity disorder (ADHD) in the public mental health sector. Although treatment algorithms for adult mental disorders have been developed, this represents one of the first attempts to develop similar algorithms for childhood mental disorders. Although these algorithms were developed initially for the public sector, the goals of this approach are to increase the uniformity of treatment and improve the clinical outcomes of children and adolescents with ADHD in a variety of treatment settings.
METHOD: A consensus conference of academic clinicians and researchers, practicing clinicians, administrators, consumers, and families was convened to develop evidence-based consensus algorithms for the pharmacotherapy of childhood ADHD. After a series of presentations of current research evidence and panel discussion, the consensus panel met and drafted the algorithms along with guidelines for implementation.
RESULTS: The panel developed consensually agreed-upon algorithms for ADHD with and without specific comorbid disorders. The algorithms consist of systematic strategies for psychopharmacological interventions and tactics to ensure successful implementation of the strategies. While the algorithms focused on the medication management of ADHD, the conference emphasized that psychosocial treatments are often a critical component of the overall management of ADHD.
CONCLUSIONS: Medication algorithms for ADHD can be developed with consensus. A companion article will discuss the implementation of these algorithms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10892234     DOI: 10.1097/00004583-200007000-00021

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  23 in total

1.  The Subjective Experience of Youth Psychotropic Treatment.

Authors:  Jerry Floersch
Journal:  Soc Work Ment Health       Date:  2004-03-01

Review 2.  Pharmacologic treatment of attention-deficit hyperactivity disorder.

Authors:  Donald E Greydanus
Journal:  Indian J Pediatr       Date:  2005-11       Impact factor: 1.967

3.  Deciding on stimulant use for childhood ADHD: maintaining focus on the key questions.

Authors:  John D McLennan
Journal:  Can Fam Physician       Date:  2006-08       Impact factor: 3.275

Review 4.  The pharmacological management of childhood anxiety disorders: a review.

Authors:  Shauna P Reinblatt; Mark A Riddle
Journal:  Psychopharmacology (Berl)       Date:  2007-01-05       Impact factor: 4.530

Review 5.  Treatment of attention-deficit hyperactivity disorder.

Authors:  L Murray; D R Patel
Journal:  Indian J Pediatr       Date:  2001-01       Impact factor: 1.967

6.  Co-existing psychiatric problems in ADHD in the ADORE cohort.

Authors:  Hans-Christoph Steinhausen; Torunn Stene Nøvik; Gisli Baldursson; Paolo Curatolo; Maria J Lorenzo; Rob Rodrigues Pereira; Stephen J Ralston; Aribert Rothenberger
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-12       Impact factor: 4.785

7.  Computer-assisted management of attention-deficit/hyperactivity disorder.

Authors:  John V Lavigne; Mina K Dulcan; Susan A LeBailly; Helen J Binns; Thomas K Cummins; Poonam Jha
Journal:  Pediatrics       Date:  2011-06-13       Impact factor: 7.124

8.  Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.

Authors:  John S Markowitz; Arthur B Straughn; Kennerly S Patrick; C Lindsay DeVane; Linda Pestreich; James Lee; Yanfeng Wang; Rafael Muniz
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

9.  Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy.

Authors:  Joseph C Blader; Nina R Schooler; Peter S Jensen; Steven R Pliszka; Vivian Kafantaris
Journal:  Am J Psychiatry       Date:  2009-11-02       Impact factor: 18.112

10.  Stimulant Medications and Cognition, Behavior and Quality of Life in Children and Youth with HIV.

Authors:  Patricia A Sirois; Lisa Aaron; Grace Montepiedra; Deborah A Pearson; Suad Kapetanovic; Paige L Williams; Patricia A Garvie; Molly L Nozyce; Kathleen Malee; Sharon L Nichols; Betsy L Kammerer; Wendy G Mitchell; Mark Mintz; James M Oleske
Journal:  Pediatr Infect Dis J       Date:  2016-01       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.